	Protective Effect of Dexmedetomidine Combined with Butorphanol on Perioperative Pulmonary Function in Patients Undergoing Laparoscopic Colorectal Cancer Resection: A Randomized, Double-Blind, 2 * 2 Factorial-Controlled Trial. Drug Des Devel Ther Li H, Zhou G, Chen H, Liu T, Xu W, Guo D, Wang S, Gao F. PMID: 41488757 [PubMed - in process]
	Development and validation of an interpretable machine learning model for predicting progression-free survival after immunotherapy in patients with non-small cell lung cancer: a multicenter study. Front Immunol Li Y, Xia J, He T, Hu Y, Zhou D, Zou D, Li B, Zhang M, Huang Z, Zhang M, Liu X, Wang M, Luo H, Lu F, Zhang C, Zhao X, Su S, Peng J. PMID: 41488620 [PubMed - in process]
	Experiences of the fatigue-pain-sleep disturbance symptom cluster among patients with lung cancer: A descriptive qualitative study. Asia Pac J Oncol Nurs Lai Q, Lu W, Xiao L, Luo Y, Yang Z, Miao J, Chen P, Zhang L. PMID: 41488216 [PubMed]
	The NGS and PCR-based Detection of EGFR Mutations in Liquid Biopsy: A Systematic Review and Meta-analysis Compared With Tissue Biopsy in Treatment-naÃ¯ve Patients With Non-small Cell Lung Cancer. Cancer Diagn Progn Molina MDSG, Guerron-Gómez G, Vargas MP, Parra-Medina R. PMID: 41487925 [PubMed - in process]
	The DDR-immune fitness score: a biomarker for guiding parp and immunotherapy synergy in extensive-stage small cell lung cancer. Front Oncol Zhang Y, Chen X, Wang D, Zhou X, Wang Y, Zhang G, Liu X. PMID: 41487593 [PubMed]
	Mapping three decades of air pollution-lung cancer research: trends, hotspots, and networks (1990-2025). Front Oncol Fan H, Wang L, Zhai L, Deng S, Li Y, Niu H, Zhao B, Gao J, Gao X. PMID: 41487586 [PubMed]
	Radiomic approach to support multidisciplinary tumor board decision-making in locally advanced non-small cell lung cancer. Front Oncol Pasello G, Kotler H, Ferro A, Bergamin L, Scagliori E, Grassi A, Aiolli F, De Nuzzo M, Schiavon M, Sepulcri M, Krengli M, Guarneri V, Caumo F, Gennaro G. PMID: 41487562 [PubMed]
	Efficacy and safety of later-line targeted therapies in advanced non-small cell lung cancer with EGFR exon 20 insertion mutations: a systematic review. Front Pharmacol Wen Q, Zhuang Y, Fu S, Pan C, Liu Z, Wang L. PMID: 41487495 [PubMed]
	First-line immunotherapy-based regimens for metastatic non-small cell lung cancer: A network meta-analysis of landmark trials. Tuberk Toraks Ismayilov R, Altunda. PMID: 41486797 [PubMed - indexed for MEDLINE]
	Overcoming Resistance in EGFR-Mutant Cancers: A Comprehensive Review of Inhibitor Evolution and SAR-Based Design. Drug Dev Res Naykwadi H, Alavala RR. PMID: 41486501 [PubMed - indexed for MEDLINE]
	Association of HMGB1 expression with prognosis of non-small cell lung cancer: a systematic review and meta-analysis. BMC Cancer Zheng T, Li X, Jin J, Zhou L. PMID: 41486138 [PubMed - as supplied by publisher]
	An updated cost-effectiveness analysis of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer: the perspective of the United States. BMC Health Serv Res Chen F, Xu X, Wang X. PMID: 41484770 [PubMed - as supplied by publisher]
	Prediction of lymph node metastasis in non-small cell lung cancer and its correlation with Ki-67 expression: a comparative study between intravoxel incoherent motion imaging and (18)F-FDG PET. BMC Med Imaging Wei W, Chen Q, Meng N, Wang X, Liu Y, Zhang J, Wu Y, Pan J, Huang Z, Yang Y, Wang Z, Liu Q, Fu F, Wang M. PMID: 41484705 [PubMed - as supplied by publisher]
	A comparison of in-the-moment and retrospective patient-reported outcome measures in advanced cancer. Support Care Cancer Geeraerts J, de Nooijer K, Pivodic L, Crombez G, Decoster L, Fontaine C, Joris S, Naert E, De Ridder M, Van den Block L. PMID: 41484597 [PubMed - indexed for MEDLINE]
	ANCA-negative pauci-immune crescentic glomerulonephritis associated with nivolumab in lung cancer. CEN Case Rep Furuyama R, Eriguchi M, Kamikawa M, Beppu Y, Tamaki H, Uemura T, Tasaki H, Nishimoto M, Kosugi T, Tanabe K, Matsui M, Samejima KI, Tsuruya K. PMID: 41484332 [PubMed - indexed for MEDLINE]
	Intracranial activity of antibody-drug conjugates in advanced non-small cell lung cancer: What have we accomplished so far? Cancer Treat Rev Cheo SW, Li MSC, Huang DD, Saw SPL, Hendriks LEL, Remon J, Menis J, Addeo A, Voon PJ. PMID: 41483736 [PubMed - as supplied by publisher]
	Liquid biopsy and tissue biopsy for the detection of EGFR mutations in patients with stage III non-small-cell lung cancer: an observational real-world study. ESMO Open Malapelle U, Nasirova F, Wang A, Cooper M, Salomonsen R, Baser E, Raiber-Moreau EA, Chuang Y, Kim YJ. PMID: 41483627 [PubMed - as supplied by publisher]
	Increased delays of care during the COVID-19 pandemic: experience of a lung cancer rapid diagnostic center. Respir Med Res Wang P, Canellas A, Millet F, Météyé C, Epaud C, Rosencher L, Antoine M, Etienne H, Barral M, Cadranel J, Parrot A, Fallet V, Lavolé EA. PMID: 41483583 [PubMed - as supplied by publisher]
	Targeting shared mechanisms of cisplatin resistance and metastasis in lung cancer for novel therapeutic strategies. Discov Oncol Liang X, Zhu X, Zhang Y, Chen M, Liu N. PMID: 41483442 [PubMed - as supplied by publisher]
	Fertility treatment and risk of non-gynecological cancer: a systematic review. Arch Gynecol Obstet Kim S, Mo JA, Kim HJ, Choe SA. PMID: 41483166 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 155344

Page 1 of 7768



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy